Craig Gracey Sells 644 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 644 shares of the company’s stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $21.73, for a total transaction of $13,994.12. Following the completion of the sale, the chief accounting officer directly owned 14,412 shares of the company’s stock, valued at $313,172.76. This trade represents a 4.28% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Craig Gracey also recently made the following trade(s):

• On Monday, August 10th, Craig Gracey sold 1,042 shares of Omada Health stock. The stock was sold at an average price of $25.00, for a total transaction of $26,050.00.
• On Wednesday, July 1st, Craig Gracey sold 637 shares of Omada Health stock. The stock was sold at an average price of $23.00, for a total transaction of $14,651.00.
• On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The shares were sold at an average price of $22.00, for a total transaction of $8,910.00.
• On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $21.00, for a total value of $43,743.00.
• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The shares were sold at an average price of $20.00, for a total value of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total value of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.

Omada Health Price Performance

Shares of Omada Health stock opened at $19.66 on Friday. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92. The business’s 50 day simple moving average is $22.63 and its two-hundred day simple moving average is $17.92. The stock has a market capitalization of $1.20 billion, a P/E ratio of 393.20 and a beta of 1.86.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The firm had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. Sell-side analysts expect that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Raymond James Financial Inc. bought a new position in Omada Health in the second quarter worth about $32,000. Bellevue Group AG lifted its holdings in Omada Health by 0.7% in the third quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock worth $5,567,000 after buying an additional 1,791 shares during the period. Quarry LP bought a new stake in Omada Health during the 4th quarter valued at approximately $29,000. Barclays PLC grew its holdings in shares of Omada Health by 14.6% during the 4th quarter. Barclays PLC now owns 14,850 shares of the company’s stock worth $234,000 after acquiring an additional 1,888 shares during the period. Finally, Versant Capital Management Inc grew its holdings in shares of Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after acquiring an additional 2,283 shares during the period.

Analysts Set New Price Targets

A number of research firms have issued reports on OMDA. Weiss Ratings upgraded shares of Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research report on Tuesday, August 11th. Robert W. Baird raised their target price on Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 12th. Needham & Company LLC restated a “buy” rating and set a $28.00 price target on shares of Omada Health in a report on Friday. Morgan Stanley reaffirmed an “overweight” rating and set a $30.00 price target on shares of Omada Health in a research report on Monday, June 22nd. Finally, Canaccord Genuity Group increased their price objective on Omada Health from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Omada Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.67.

Omada Health News Summary

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Analyst support remains strong: BTIG Research reaffirmed its “buy” rating and set a $35 price target, while Needham & Company also maintained a “buy” rating with a $28 target. These targets imply significant potential upside and reinforce confidence in Omada’s growth outlook.
• Positive Sentiment: Investor Day could provide new growth targets: Omada held its inaugural Investor Day and planned to present updated long-term financial targets. More ambitious revenue, profitability, or membership goals could improve investor confidence if management’s outlook exceeds current expectations. Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
• Neutral Sentiment: Investor Day transcript available: The transcript may offer additional detail on Omada’s strategy and financial targets, but the supplied report does not identify specific changes that would immediately alter earnings expectations. Omada Health Analyst/Investor Day Transcript
• Negative Sentiment: Chief accounting officer sold shares: CAO Craig Gracey sold 644 shares for approximately $14,000, reducing his direct ownership by 4.28%. The relatively small transaction is not necessarily a sign of deteriorating fundamentals, but insider selling can create short-term negative sentiment. SEC Insider Transaction Filing

About Omada Health

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.